Gspt1 degrader toxicity
WebAug 20, 2024 · Treatment with all these degraders at 50 nM for 24 h could induce > 70% degradation of the BTK and GSPT1 proteins; among them, a representative degrader named GBD-9, has the greatest effect on ... WebJan 26, 2024 · Here, we profile 14 closely-related thalidomide derivatives in CRBN occupancy, and IKZF1 and GSPT1 degradation cell-based assays, and use crystal …
Gspt1 degrader toxicity
Did you know?
WebJul 14, 2016 · Abstract. Immunomodulatory drugs bind to cereblon (CRBN) to confer differentiated substrate specificity on the CRL4 (CRBN) E3 ubiquitin ligase. Here we report the identification of a new cereblon modulator, CC-885, with potent anti-tumour activity. The anti-tumour activity of CC-885 is mediated through the cereblon-dependent ubiquitination … WebJan 1, 2024 · We showed that PS-RC-1 potently induces degradation of IKZF1 and IKZF3 but not BTK or GSPT1, accounting for its toxicity in Mino cells. We further decreased the molecular size of PS-RC-1 by shrinking the BTK binding moiety and developed PS-2 as a potent BTK and IKZF1/3 triple degrader with high specificity. ... 1.6, 8, 40, 200, and 1000 …
WebJul 16, 2024 · SJ6986, a Thalidomide analogue, is a selective and orally active G1 to S phase transition 1 (GSPT1) and GSPT2 degrader. SJ6986 displays selectivity over ~9000 proteins, including the classical IMiD … WebJan 9, 2024 · As CC-885 can induce the degradation of GSPT1 while other IMiDs do not, it may have extra toxicity from other IMiDs. More studies on the activity and toxicity …
WebApr 8, 2024 · Orum developed a proprietary class of GSPT1 degrader molecules, paired them with a HER2-targeting antibody, pertuzumab, and screened numerous candidate conjugates to identify a molecule with the ... WebAlthough CC-885 can promote apoptosis and the subsequent death of lenalidomide-insensitive cells, it exhibits toxicity and poor specificity for protein degradation. CC-90009, a compound that induces the degradation of GSPT1, has demonstrated increased selectivity against non-cancer cells and lower toxicity [30].
WebJan 17, 2024 · ORM-5029, the latest disclosed DAC or Antibody neoDegrader Conjugate (AnDC™), aims to deliver a GSPT1 degrader (Smol006) to HER2-expressing cells via pertuzumab. This AnDC™ has demonstrated stronger cytotoxicity than other GSPT1 degraders and anti-tumor activity comparable to that of DS-8201a . The toxicity of ORM …
WebJun 4, 2024 · BTX-1188 could prevent systemic inflammatory dose-limiting toxicities that are usually attributed to pure GSPT1 degradation due to its immunomodulatory properties from the IKZF1/3 degradation. ... was initiated to assess the safety and toxicity ... Pasis A, et al. BTX-1188, a first-in-class dual degrader of GSPT1 and IKZF1/3, for treatment of ... higbee\u0027s dept store cleveland ohioWebJun 28, 2024 · The first-in-class GSPT1 degrader CC-885 demonstrated cytotoxicity across multiple cell lines derived from different tumor types, as well as efficacy against primary … how far is canada from indianapolisWebApr 4, 2024 · Double-mechanism degrader Treatment of complicated diseases, such as cancer, often require more than one targets. Yang et al reported that a small molecule, GBD-9, that can target both bruton... higbee\u0027s display rackWebA range of new targeted drugs have been developed for cancer therapy [1,2]. However, the number of drugs currently in development does not match the number of proteins targeted for cancer treatment. Many potential oncotargets are difficult to inhibit because they are non-enzyme proteins that lack active sites for small molecules, which are mostly occupancy … higbee\\u0027s downtown clevelandWebCK1α and GSPT1 were subsequently identified as substrates for specific ligands, indicating that this molecular class could be tuned for selective protein degradation. Structural studies showed that the thalidomide analogues bind to a shallow hydrophobic pocket on the surface of cereblon, and scaffold a protein-protein interaction with target ... higbee\\u0027s dept store cleveland ohioWebWe showed that PS-RC-1 potently induces degradation of IKZF1 and IKZF3 but not BTK or GSPT1, accounting for its toxicity in Mino cells. We further decreased the molecular size of PS-RC-1 by shrinking the BTK binding moiety and developed PS-2 as a potent BTK and IKZF1/3 triple degrader with high specificity. how far is canada from new mexicoWebMar 25, 2024 · CC-885 was moderately toxic to fibroblasts from an unaffected individual (Figure 5A and Supplementary Figure S2) or MPS I-H patient ... a cereblon E3 ligase … how far is canada from me by car